Gene · 4891
Papers3,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Role of APEX1 During Ferroptosis. | Front Oncol | 2022 | 35311089 | PubTator, text mining | PubMed |
| The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35309918 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| Hypoxia and chronic kidney disease. | EBioMedicine | 2022 | 35290825 | PubTator, text mining | PubMed |
| Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells. | Stem Cells Int | 2022 | 35287356 | PubTator, text mining | PubMed |
| Banxia-Houpu decoction diminishes iron toxicity damage in heart induced by chronic intermittent hypoxia. | Pharm Biol | 2022 | 35286247 | PubTator, text mining | PubMed |
| Identification of two-dimensional copper signatures in human blood for bladder cancer with machine learning. | Chem Sci | 2022 | 35282611 | PubTator, text mining | PubMed |
| Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases. | Front Pharmacol | 2022 | 35281917 | PubTator, text mining | PubMed |
| Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer. | Front Oncol | 2022 | 35280796 | PubTator, text mining | PubMed |
| Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials. | Nutrients | 2022 | 35276902 | PubTator, text mining | PubMed |
| Trophoblast Differentiation Affects Crucial Nutritive Functions of Placental Membrane Transporters. | Front Cell Dev Biol | 2022 | 35273963 | PubTator, text mining | PubMed |
| Decreased serum iron concentration and total iron binding capacity are associated with serious Crohn's disease. | Sci Rep | 2022 | 35273280 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Modulatory Effects of Fractalkine on Inflammatory Response and Iron Metabolism of Lipopolysaccharide and Lipoteichoic Acid-Activated THP-1 Macrophages. | Int J Mol Sci | 2022 | 35269771 | PubTator, text mining | PubMed |
| Minerals and Cancer: Overview of the Possible Diagnostic Value. | Cancers (Basel) | 2022 | 35267564 | PubTator, text mining | PubMed |
| Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology. | Diabetes Metab Syndr Obes | 2022 | 35264864 | PubTator, text mining | PubMed |
| "Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases". | Pharm Res | 2022 | 35257286 | PubTator, text mining | PubMed |
| Systemic review of genetic and epigenetic factors underlying differential toxicity to environmental lead (Pb) exposure. | Environ Sci Pollut Res Int | 2022 | 35244845 | PubTator, text mining | PubMed |
| Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial. | PLoS One | 2022 | 35239732 | PubTator, text mining | PubMed |
| Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer. | Genes Dis | 2022 | 35224151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4891/papers?page=45